- Home
- ACFN vs BRNS Comparison
ACFN vs BRNS Comparison
Compare ACFN & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACFN
- BRNS
- Stock Information
- Founded
- ACFN 1986
- BRNS 2016
- Country
- ACFN United States
- BRNS United Kingdom
- Employees
- ACFN N/A
- BRNS N/A
- Industry
- ACFN Military/Government/Technical
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- ACFN Consumer Discretionary
- BRNS Health Care
- Exchange
- ACFN Nasdaq
- BRNS Nasdaq
- Market Cap
- ACFN 63.5M
- BRNS 55.9M
- IPO Year
- ACFN N/A
- BRNS 2021
- Fundamental
- Price
- ACFN $25.11
- BRNS $1.26
- Analyst Decision
- ACFN
- BRNS Strong Buy
- Analyst Count
- ACFN 0
- BRNS 1
- Target Price
- ACFN N/A
- BRNS $3.00
- AVG Volume (30 Days)
- ACFN 15.4K
- BRNS 115.5K
- Earning Date
- ACFN 11-10-2025
- BRNS 11-06-2025
- Dividend Yield
- ACFN N/A
- BRNS N/A
- EPS Growth
- ACFN 1520.82
- BRNS N/A
- EPS
- ACFN 2.84
- BRNS N/A
- Revenue
- ACFN $13,202,000.00
- BRNS $14,969,000.00
- Revenue This Year
- ACFN N/A
- BRNS N/A
- Revenue Next Year
- ACFN N/A
- BRNS N/A
- P/E Ratio
- ACFN $8.82
- BRNS N/A
- Revenue Growth
- ACFN 50.98
- BRNS 1766.46
- 52 Week Low
- ACFN $17.22
- BRNS $0.64
- 52 Week High
- ACFN $33.00
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- ACFN 45.65
- BRNS 45.50
- Support Level
- ACFN $23.00
- BRNS $1.20
- Resistance Level
- ACFN $26.47
- BRNS $1.34
- Average True Range (ATR)
- ACFN 1.74
- BRNS 0.11
- MACD
- ACFN -0.04
- BRNS -0.02
- Stochastic Oscillator
- ACFN 46.89
- BRNS 19.67
About ACFN Acorn Energy Inc. Common Stock
Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.